Emerging research suggest this peptide, a dual stimulator targeting both incretin and glucose-dependent insulinotropic polypeptide , could provide a promising step forward for obesity treatment. https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026